Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Top Indian CROs Unite On Centralized Biometric Database Covering Trial Volunteers

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - Leading Indian clinical research organizations have united to create a centralized biometrics database in what is seen as the first ever concerted attempt to avoid duplication of volunteers in various clinical trials within the "wash-out period.

You may also be interested in...



Will Spiraling Costs Retard Growth Of Clinical Research In India? The Jury Is Out

MUMBAI - From being a preferred destination for conducting clinical research to facing competitive pressure from countries like Malaysia, the Indian clinical research industry may miss the opportunity of emerging as a global hub for multinational drug companies

Indian Clinical Research Industry Divided Over Mandatory Registration Of Clinical Trials From June 15

NEW DELHI - As the June 15 deadline approaches for India's mandatory registration of clinical trials in a publicly accessible library, the industry is bracing itself to put trial details online with mixed reactions

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).

UsernamePublicRestriction

Register

ID1131516

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel